The specific treatment plan should be based on the patient’s age, systemic condition, tumor TNM stage and Gleason score. 1.Surgical treatment. (1) Indications for surgery: ① Suitable for limited prostate cancer, clinical stage T1 to T2C, for clinical stage T3 there are advocates for radical surgery after neoadjuvant therapy. ②Life expectancy R10 years. ③Health status: Only patients in good physical condition without serious cardiopulmonary disease are suitable for radical surgery. ④Management of patients with high risk of PSA or Gleason score: For limited prostate cancer with PSA > 20ng/ml or Gleason score 8 that meets the above staging and life expectancy, other adjuvant treatment can be given after radical surgery. ⑤ Palliative surgery is feasible for metastatic prostate cancer. (2) Surgical procedures: ① Radical surgery for trans-perineal prostate cancer. ②Radical surgery for retropubic prostate cancer. ③Laparoscopic radical prostate cancer surgery. ④Palliative surgery: including transurethral electrodesiccation/laser/cryotherapy of the prostate, bilateral orchiectomy, etc.